• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • NMPA Monthly Newsletter

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

China NMPA Newsletter – October 2023

2023-11-30

Featured Articles China Continues To Explore Real-World Evidence To Enhance Clinical Evaluation In a recent conference held from…

China’s State Council Approves Blueprint For Beijing’s National Service Industry Pilot Zone

2023-11-27

In a monumental decision, China's State Council has officially given the nod to the ambitious plan for constructing…

China Continues To Explore Real-World Evidence To Enhance Clinical Evaluation

2023-11-23

In a recent conference held from October 31 to November 1, the National Medical Products Administration's Medical Device…

Medical Device Quality Alert: NMPA Inspection Results

2023-11-21

The National Medical Products Administration (NMPA) has released findings from its recent quality inspection, revealing that 20 batches…

China Hainan Province Implements New Regulations For Patients Carrying Medications And Medical Devices Upon Hospital Discharge – Take Away Use Policy

2023-11-21

China Hainan Province has recently put into effect the "Management Measures for the Carrying and Use of Clinically…

China Tightens Regulations On Radiofrequency Beauty Treatment Devices

2023-11-20

In a significant regulatory update, China's National Medical Products Administration (NMPA) has announced a comprehensive overhaul of the…

NMPA Notice On Unannounced Inspections

2023-11-02

Recently, NMPA conducted unannounced inspections of four enterprises and found the following major deficiencies in their quality management…

China NMPA Newsletter – September 2023

2023-10-30

Featured Articles NMPA New Approvals in September 2023 In September 2023, NMPA approved 187 medical devices, including 25…

NMPA Suspends Import And Use Of Swedish XVIVO Perfusion System Due To Major Findings From Remote Overseas Inspection

2023-10-27

Recently, the NMPA has announced the suspension of import, distribution, and use of the Swedish XVIVO Perfusion System,…

NMPA New Approvals In September 2023

2023-10-27

In September 2023, NMPA approved 187 medical devices, including 25 Class III imported products, 24 Class II imported…

NMPA Preparing The Guidelines For Registration Review Of Real-World Study Designs And Statistical Analyses For Medical Devices

2023-10-27

On September 28, 2023, NMPA issued a notice collecting public comments on the Guidelines for Registration Review of…

China NMPA Newsletter – August 2023

2023-09-30

Featured Articles NMPA New Approvals in August 2023 In August 2023, NMPA approved 288 medical devices, including 33…
« Prev...23456...101214...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7